ClinicalTrials.Veeva

Menu

Brain Metastasis Development Mechanism in BCBM Patients

Samsung Medical Center logo

Samsung Medical Center

Status

Enrolling

Conditions

Breast Cancer
Brain Metastasis

Treatments

Procedure: WGS/TME evaluation

Study type

Interventional

Funder types

Other

Identifiers

NCT06330870
BCBM_Breast

Details and patient eligibility

About

This study is the experimental study for brain metastasis development mechanism in patients with breast cancer with brain metastasis

Enrollment

30 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Breast cancer
  • Brain metastasis curative surgery patient

Exclusion criteria

  • Gamma Knife surgery patient

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

WGS/TME evaluation
Experimental group
Description:
This is not intervention clinical trial design. We explore whole genome sequencing and tumor microenvironment evaluation for brain metastasis specimen in breast cancer patients.
Treatment:
Procedure: WGS/TME evaluation

Trial contacts and locations

1

Loading...

Central trial contact

Mee Ryung Hong; Ji-Yeon Kim

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems